Cargando…
From diagnosis to therapy in Duchenne muscular dystrophy
Genetic approaches for the diagnosis and treatment of inherited muscle diseases have advanced rapidly in recent years. Many of the advances have occurred in the treatment of Duchenne muscular dystrophy (DMD), a muscle wasting disease where affected boys are typically wheelchair bound by age 12 years...
Autores principales: | Babbs, Arran, Chatzopoulou, Maria, Edwards, Ben, Squire, Sarah E., Wilkinson, Isabel V.L., Wynne, Graham M., Russell, Angela J., Davies, Kay E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329342/ https://www.ncbi.nlm.nih.gov/pubmed/32597486 http://dx.doi.org/10.1042/BST20190282 |
Ejemplares similares
-
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model
por: Babbs, Arran, et al.
Publicado: (2020) -
Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Molecular Analysis and Diagnosis of Duchenne Muscular Dystrophy
por: Forrest, S. M., et al.
Publicado: (1988) -
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
por: Goyenvalle, Aurélie, et al.
Publicado: (2011)